ASCIA News
-
ASCIA COVID-19 update
9 November 2020: In Australia and New Zealand we are currently in the fortunate situation of having almost no community transmission of COVID-19, unlike most other countries. However, work continues on prevention and treatment of COVID-19, including the local production of a... -
ASCIA Immunodeficiency Strategy for Australia and New Zealand
6 November 2020: It is a pleasure to announce that the ASCIA Immunodeficiency Strategy for Australia and New Zealand has now been completed and is available at www.nationalimmunodeficiencystrategy.org.au Over the past two years ASCIA has worked in collaboration with patient... -
New TAPID SCID publication
30 October 2020: A new position paper, Diagnosis and management of severe combined immunodeficiency (SCID) in Australia and New Zealand, submitted on behalf of the ASCIA Transplantation and Primary Immunodeficiency (TAPID) group, has been published in the Journal of Paediatr... -
International Mastocytosis Day
20 October 2020: On International Mastocytosis and Mast Cell Diseases Awareness Day (20 October), landmarks and venues across Australia are lighting up to raise awareness of Mastocytosis and Mast Cell Diseases. For more Information go to https://mastocytosis.org.au/ A mastoc... -
Important change to TGA Authorised Prescriber scheme
19 October 2020: The Therapeutic Goods Administration (TGA) has streamlined the Authorised Prescriber application process to access allergens for skin prick and intradermal testing, by removing the requirement for Human Research Ethics Committee (HREC) approval or specialist... -
Welcome to the new ASCIA President
At the ASCIA Annual General Meeting (AGM) on 3 September 2020 we welcomed the new ASCIA President, Professor Michaela Lucas. Professor Lucas is a clinical immunology/allergy specialist and immunopathologist based in Perth, Western Australia, and Chair of the highly successfu... -
ASCIA WA Immunology and Clinical Grand Rounds (CGR) meeting on Saturday 14 November 2020
12 October 2020: ASCIA members are invited to participate in the ASCIA WA Immunology and Clinical Grand Rounds (CGR) meeting on Saturday 14 November 2020, 08.30-16.00. This event will be held at the Harry Perkins Institute of Medical Research McCusker Auditorium, 6 Verdun St... -
New online All about Allergens Food Service Training for Hospitals
29 September 2020: New online All about Allergens food service training for hospitals was successfully launched by the National Allergy Strategy (via a Zoom meeting) last Thursday 24 September 2020. The training is available free of charge at foodallergytraining.org.au The l...
-
Site updated: 9 Nov 2020
ASCIA Update
Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list here...
About ASCIA
ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases
Quick Links
About ASCIA
ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...
The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...
Disclaimer I Privacy
The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...
ASCIA respects your privacy. Read our privacy policy here...
Sponsors | Advertising
ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites.
The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.
Accreditiation
This site complies with the HONcode standard for trustworthy health information: verify here.